Matthias Wieser

Matthias Wieser is a Full Professor in the Department of Clinical Psychology at the Erasmus School of Social and Behavioural Sciences, Erasmus University Rotterdam. His work bridges experimental psychopathology and clinical neuroscience, focusing on the cognitive and affective mechanisms of fear, anxiety, and pain. He employs psychophysiological methods such as EEG and skin conductance to study emotional processing and learning in both healthy individuals and those with psychiatric conditions.

His research interests include:

• Experimental psychopathology: biased threat processing, fear conditioning, extinction, generalization, and differentiation of anticipatory anxiety from phasic fear
• Experimental pain research: affective modulation of pain, placebo/nocebo effects, pain anticipation, and regulation of acute pain
• Contextual influences on social vision and facial processing

The analysis of his recent publications reveals a consistent focus on the interplay between emotion and cognition, particularly in aversive learning and pain perception. His work often integrates neurocognitive measures with clinical insights, aiming to translate basic findings into improved diagnostic and therapeutic strategies for anxiety and pain disorders. Key methodologies include psychophysiological monitoring, experimental paradigms, and longitudinal data analysis.

Scientific award:

• The use of state-of-the-art VR technologies for diagnosis and treatment of socio-affective cognition deficits in mental disorders – From bench to bedside (2021)

Matthias Wieser serves as an editor for the journal Cognition & Emotion since 2018, contributing to academic peer review and editorial leadership. While specific grant details are not listed, his involvement in interdisciplinary projects—especially those involving VR applications—suggests active participation in funded research initiatives. He collaborates widely across institutions and disciplines, particularly in neuroscience, psychology, and mental health technology.

He is involved in public engagement, with media appearances discussing the impact of neurological disorders on patients and health systems. His research network includes collaborations in multiple countries, reflecting an international reach in clinical and cognitive neuroscience.